| Gene symbol | CMM | Synonyms | CMM1, DNS, FAMMM, MLM | Type of gene | unknown |
| Chromosome | 1 | Map location | 1p36 | dbXrefs | |
| Description | cutaneous malignant melanoma/dysplastic nevus | ||||
| GTO ID | GTC1373 |
| Trial ID | NCT01278940 |
| Disease | Malignant Adenoma |
| Altered gene | CMM |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | Dendritic cells Vaccines |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Phase I/II Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma |
| Year | 2002 |
| Country | Norway |
| Company sponsor | Oslo University Hospital |
| Other ID(s) | DC malignant melanoma |
| Vector information | |||
|
|||
| Cohort1: DC | |||||
|
|||||
| Cohort2: DC_IL-2 | |||||
|
|||||